News
Small study suggests natural HCV clearance is caused by AR3-antibody response
Cross-genotype and neutralizing antibodies, especially targeting AR3, contribute to HCV clearance and long-term protection.
News
Ebola outbreak: WHO/OCHA call for more aid, better security
Security, public trust, and a lack of resources are significant barriers to countering the current Ebola epidemic in the Democratic Republic of...
News
Patients with COPD at heightened risk for community-acquired pneumonia requiring hospitalization
COPD patients were about 18 times more likely to develop community-acquired pneumonia requiring hospitalization.
News
Microvascular disease: An independent and exacerbating risk factor for amputation
The presence of microvascular disease plus peripheral artery disease resulted in a more than 20-fold increased risk of amputation than MVD or PAD...
News
FDA panel: Continue using paclitaxel-eluting PAD devices, with caveats
Although the benefits of the devices were clear, the panel felt there should be a label change to warn of the late mortality signal seen in a key...
Article
FDA panel to reassess the fate of paclitaxel-coated PAD devices
The FDA is requesting the panel’s input regarding the presence and magnitude of the increased mortality signal and its potential causes.
News
DOPPS participation associated with lower HCV rates in dialysis patients
HCV infection decreased from 2.9 to 1.2 per 100 patient-years in countries participating in the initial phase of DOPPS.
News
Higher serum leptin levels associated with PAD
Serum leptin levels are positively and independently associated with PAD.
News
HCC linked to mitochondrial damage, iron accumulation from HCV
Mitochondrial damage and iron accumulation from HCV are linked to the development of hepatocellular carcinoma.
